Drug Channels

SEPTEMBER 14, 2022

I invite you to join me for three new video webinars during 2023. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. I’ll share DCI’s latest market data to help you stay on top of new developments. d/b/a Drug Channels Institute.

Drugs 97

Drugs Marketing 97

Drug Channels

MARCH 29, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. d/b/a Drug Channels Institute. to 1:30 p.m.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Marketing Drugs 97

Drug Channels

MARCH 7, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook This event will be broadcast live on Friday, March 31, 2023, from 12:00 p.m. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drug Channels

MAY 22, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. to 1:30 p.m.

Pharmacy 97

Pharmacy Drugs Marketing Therapies 97

Drug Channels

NOVEMBER 15, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The Outlook 2022 marks our third annual outlook webinar.

Specialty Pharmacies 72

Specialty Pharmacies Biosimilars Drugs Pharmacy 72

Drug Channels

DECEMBER 15, 2022

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channels Outlook 2023. Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market.

Marketing 98

Marketing Drugs Research Pharmacy 98

PPD

JANUARY 15, 2025

Accelerate customer speed to market With a modern and integrated user experience, AI solutions put the right data and insights into the right hands in real time. As a result, drug developers make better decisions more quickly (removing 50% of study timeline whitespace) to bring new therapies to market faster. Get in touch.

Clinical Trials 95

Clinical Trials Trials Clinical Research Drug Development 95

Drug Channels

MAY 23, 2023

In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription dispensing revenues reached $621 billion in 2023, driven by accelerating GLP-1 prescriptions and an expanding post-pandemic market. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. d/b/a Drug Channels Institute. Read on for details and my commentary below.

Pharmacy 98

Pharmacy Marketing Hospitals Drugs 98

Drug Channels

SEPTEMBER 25, 2024

Drug Channel Institute is pleased to announce The Drug Channels 2025 Video Webinar Series. Fein for three live video webinars during 2025. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. drug channel.

Drugs 52

Drugs Marketing 52

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. How will GoodRx and Mark Cuban Cost Plus Drug Company affect the pharmacy industry? d/b/a Drug Channels Institute. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

SEPTEMBER 20, 2023

Drug Channel Institute is pleased to announce The Drug Channels 2024 Video Webinar Series. Fein for three live video webinars during 2024. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. drug channel.

Drugs 52

Drugs Marketing 52

Drug Channels

JUNE 20, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Drug Channels

DECEMBER 13, 2024

This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If As you will see below, CMS projects that outpatient prescription drugs dispensed by retail and mail pharmacies will remain a small share of total U.S. If you sign up before 12 p.m. spending on healthcare.

Government 98

Government Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

AUGUST 1, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. d/b/a Drug Channels Institute. Click here if you can’t see the video below.

Marketing 98

Marketing Drugs 98

Drug Channels

JUNE 1, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest live video webinar: Drug Channels Update: 340B Controversies and Outlook. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Drugs Marketing 52

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. d/b/a Drug Channels Institute. healthcare spending. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

SEPTEMBER 7, 2022

As regular readers know, the biosimilar boom for provider-administered drugs has been accelerating. In many therapeutic areas, biosimilars’ market share is approaching 80%. That’s when Humira, the best-selling drug in the U.S., d/b/a Drug Channels Institute. Prices are dropping while adoption accelerates.

Biosimilars 98

Biosimilars Marketing Drugs Production 98

Drug Channels

AUGUST 6, 2024

I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market. Click here if you can’t see the video below.

Pharmacy 90

Pharmacy Hospitals Marketing Drugs 90

Drug Channels

SEPTEMBER 24, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. That means it’s time to update Drug Channels Institute’s (DCI) annual analysis of pharmacist salaries and employment. d/b/a Drug Channels Institute.

Hospitals 69

Hospitals Marketing Drugs Pharmacy 69

Drug Channels

JULY 29, 2022

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

OCTOBER 5, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. d/b/a Drug Channels Institute. Click here if you can’t see the video below.

Pharmaceuticals 97

Pharmaceuticals Drugs Marketing 97

Fierce BioTech

JANUARY 9, 2024

This webinar provides a roadmap for organizations seeking to marry scientific excellence with market access acumen, driving transformative change for the benefit of patients. Listing Image QuartzListingLogo_250x190_clarivate.png Listing Introduction From R&D Promise to In-market Wins. Click here to login.

Marketing 52

Marketing Drugs Science Disease 52

Drug Channels

MAY 2, 2023

In my most recent video webinar , I explored how the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the prescription market. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Drugs Marketing 97

Drug Channels

JULY 20, 2022

Join me next week for my new live video webinar, Specialty Drugs Update: Trends, Controversies, and Outlook , on July 29, 2022, from 12:00 p.m. I’ll cover market trends, payer strategies, channel developments, key trends that will help you plan for the future, and more. d/b/a Drug Channels Institute. to 1:30 p.m.

Biosimilars 98

Biosimilars Pharmacy Drugs Marketing 98

Drug Channels

JUNE 21, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022. d/b/a Drug Channels Institute.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Drugs Marketing 97

Drug Channels

JULY 25, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. The highly-consolidated PBM market notched another year of increased concentration. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 5, 2022

The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. Significant business relationships among the largest companies continue to shift market share.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Patients get access to market prices that can be lower than their PBM’s contracted rate. d/b/a Drug Channels Institute. Links below.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drug Channels

DECEMBER 12, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2023. During Friday’s webinar, I’ll be sharing my updated thoughts about the IRA’s impact on manufacturers, Part D plans, and patient behavior. d/b/a Drug Channels Institute. 117-169).

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Alta Sciences

FEBRUARY 8, 2024

The FDA guidance, Evaluating Drug Effects on the Ability to Operate a Motor Vehicle , indicates that testing in early-phase clinical development should emphasize sensitivity over specificity in CNS effects. In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G.

Clinical Trials 52

Clinical Trials Trials Clinical Pharmacology Clinical Development 52

Drug Channels

JANUARY 21, 2022

Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. On February 22nd at 1:00 pm ET, ConnectiveRx will host Four Big Implications for Patients and the Prescription Journey in 2022 , a free webinar about the pandemic’s impact on key healthcare stakeholders. Read on for Chris’ insights.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

DECEMBER 17, 2020

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. Drug pricing perceptions always seem to lag reality. The biosimilar market is finally beginning to fulfill its promise. d/b/a Drug Channels Institute.

Biosimilars 52

Biosimilars Marketing Regulations FDA 52

Drug Channels

DECEMBER 13, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. d/b/a Drug Channels Institute. Click here to see the original post and comments from August 2021.

Pharmacy 98

Pharmacy Marketing Drugs 98